Oak Thistle LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Oak Thistle LLC’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,320	Closed	-$2.6M	–	488
2026 Q1	$2.6M	Buy	+9,320	New	+$2.68M	0.25%	147
2025 Q4	–	Sell	-3,993	Closed	-$1.12M	–	507
2025 Q3	$1.12M	Buy	3,993 +2,252	+129%	+$613K	0.17%	243
2025 Q2	$420K	Buy	1,741 +678	+64%	+$160K	0.06%	386
2025 Q1	$259K	Buy	+1,063	New	+$320K	0.05%	375
2024 Q4	–	Sell	-2,453	Closed	-$821K	–	415
2024 Q3	$821K	Buy	2,453 +1,306	+114%	+$415K	0.27%	148
2024 Q2	$313K	Buy	+1,147	New	+$334K	0.23%	193
2024 Q1	–	Sell	-1,913	Closed	-$618K	–	317
2023 Q4	$618K	Buy	1,913 +648	+51%	+$203K	0.18%	241
2023 Q3	$453K	Buy	+1,265	New	+$488K	0.13%	314
2023 Q2	–	Sell	-1,744	Closed	-$835K	–	361
2023 Q1	$835K	Buy	+1,744	New	+$816K	0.49%	24
2022 Q4	–	Sell	-533	Closed	-$222K	–	163
2022 Q3	$222K	Buy	533 +31	+6%	+$15.5K	0.8%	70
2022 Q2	$248K	Sell	502 -698	-58%	-$364K	0.48%	106
2022 Q1	$675K	Buy	+1,200	New	+$723K	0.36%	94

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Oak Thistle LLC's BIO Position: Q2 2026 in Review

Oak Thistle LLC sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 9,320 shares — an estimated $2.6M sold.

Oak Thistle LLC first reported a position in BIO in Q1 2022 and held it in 12 quarters. The position peaked at $2.6M in Q1 2026. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Oak Thistle LLC reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
Oak Thistle LLC sold 9,320 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $2.6M.
Oak Thistle LLC first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and held it in 12 quarters.
Oak Thistle LLC's Bio-Rad Laboratories Class A position peaked at $2.6M in Q1 2026.
397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Oak Thistle LLC's 13F filing for Q2 2026, filed 21 Jul 2026.